Tag: Heart / Stroke-Related: Stroke
Subarachnoid Bleed One of the Most Common Cardiovascular, Neurologic Causes of Death
Absolute number of subarachnoid hemorrhage cases increased, but age-standardized burden rates decreased between 1990 and 2021
Longer In-Bed Time Linked to Small Vessel Disease Burden in TIA/Mild Stroke
Longer sleep duration linked to presence of cerebral microbleeds; longer in-bed time linked to lower total MoCA score
Intravenous Tenecteplase Beneficial Before Endovascular Thrombectomy
Higher functional independence seen at 90 days for patients with acute ischemic stroke due to large vessel occlusion who present within 4.5 hours
No Benefit Seen for Revascularization Added to Drug Therapy in Carotid Stenosis
Addition of revascularization to optimized medical therapy not beneficial in patients with carotid stenosis ≥50 percent and low or intermediate predicted stroke risk
Early Combination of Lipid-Lowering Therapy Beneficial After Myocardial Infarction
In a recent study, one-year MACE incidences were 1.79, 2.58, and 4.03 per 100 patient-years for early, late, and no ezetimibe added to statins
Most Patients Newly Diagnosed With A-Fib Do Not Receive Anticoagulants
One-year stroke risk was 0.7 and 1.8 percent for patients with CHA2DS2-VA scores of 1 to 4 and 5 to 8
Age-Adjusted Ischemic Stroke Mortality Increased Since 2009
Most pronounced increases seen in nonmetropolitan areas; proportion of deaths at home has increased
Study Sheds Light on Role of Risk Factors in Young-Onset Cryptogenic Ischemic Stroke
Traditional risk factors contribute most to young-onset CIS without patent foramen ovale; nontraditional risk factors more important in CIS with PFO
17 Modifiable Risk Factors Shared by Stroke, Dementia, and Late-Life Depression
Authors say these factors can inform steps individuals can take to lower their risks for age-related brain diseases
Alteplase Increases Frequency of Functional Independence After Posterior Circulation Stroke
Findings seen in patients with posterior circulation stroke and with no planned thrombectomy who received alteplase 4.5 to 24 hours after stroke onset